Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.

MacGrogan D, Kalakonda N, Alvarez S, Scandura JM, Boccuni P, Johansson B, Nimer SD.

Genes Chromosomes Cancer. 2004 Nov;41(3):203-13.

PMID:
15334543
2.

Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies.

Bench AJ, Li J, Huntly BJ, Delabesse E, Fourouclas N, Hunt AR, Deloukas P, Green AR.

Br J Haematol. 2004 Dec;127(5):509-18.

PMID:
15566354
3.

C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia.

Koike M, Chumakov AM, Takeuchi S, Tasaka T, Yang R, Nakamaki T, Tsuruoka N, Koeffler HP.

Leuk Res. 1997 Sep;21(9):833-9.

PMID:
9393598
5.

Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies.

Li J, Bench AJ, Vassiliou GS, Fourouclas N, Ferguson-Smith AC, Green AR.

Proc Natl Acad Sci U S A. 2004 May 11;101(19):7341-6. Epub 2004 Apr 30.

7.

Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.

Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C.

Exp Hematol. 1995 Oct;23(11):1160-6.

PMID:
7556525
8.

Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.

Horrigan SK, Arbieva ZH, Xie HY, Kravarusic J, Fulton NC, Naik H, Le TT, Westbrook CA.

Blood. 2000 Apr 1;95(7):2372-7.

9.

Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).

Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S, Champion KM, Li J, Whittaker P, Stavrides G, Hunt AR, Huntly BJ, Campbell LJ, Bentley DR, Deloukas P, Green AR.

Oncogene. 2000 Aug 10;19(34):3902-13.

10.

Id2 expression increases with differentiation of human myeloid cells.

Ishiguro A, Spirin KS, Shiohara M, Tobler A, Gombart AF, Israel MA, Norton JD, Koeffler HP.

Blood. 1996 Jun 15;87(12):5225-31.

11.

Mutation in TET2 in myeloid cancers.

Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F, Alberdi A, Lécluse Y, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Viguié F, Fontenay M, Vainchenker W, Bernard OA.

N Engl J Med. 2009 May 28;360(22):2289-301. doi: 10.1056/NEJMoa0810069.

12.

High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.

Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL, Dastugue N, Macintyre E, Denis C, Bauters F, Kerckaert JP, Cosson A, Fenaux P.

Blood. 2000 Oct 15;96(8):2862-9.

13.

FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases.

Luan X, Ramesh KH, Cannizzaro LA.

Cytogenet Cell Genet. 1998;81(3-4):183-8.

PMID:
9730598
15.

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.

Boultwood J, Pellagatti A, Watkins F, Campbell LJ, Esoof N, Cross NC, Eagleton H, Littlewood TJ, Fidler C, Wainscoat JS.

Br J Haematol. 2004 Aug;126(4):508-11.

PMID:
15287943
16.

Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML.

Zheng R, Klang K, Gorin NC, Small D.

Leuk Res. 2004 Feb;28(2):121-6. Erratum in: Leuk Res. 2004 Nov;28(14):1241.

PMID:
14654075
17.

L3mbtl, the mouse orthologue of the imprinted L3MBTL, displays a complex pattern of alternative splicing and escapes genomic imprinting.

Li J, Bench AJ, Piltz S, Vassiliou G, Baxter EJ, Ferguson-Smith AC, Green AR.

Genomics. 2005 Oct;86(4):489-94.

PMID:
16081246
18.

A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomes.

Koga H, Matsui S, Hirota T, Takebayashi S, Okumura K, Saya H.

Oncogene. 1999 Jul 1;18(26):3799-809.

19.

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.

Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Stone RM, DeAngelo DJ, Galinsky IA, Issa JP, Clarke MF, Look AT.

Nat Med. 2007 Jan;13(1):78-83. Epub 2006 Dec 10.

PMID:
17159988
20.

Expression of angiopoietin-1 and its receptor TEK in hematopoietic cells from patients with myeloid leukemia.

Müller A, Lange K, Gaiser T, Hofmann M, Bartels H, Feller AC, Merz H.

Leuk Res. 2002 Feb;26(2):163-8.

PMID:
11755466

Supplemental Content

Support Center